YLT11 a novel PLK4 inhibitor inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect

YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect

03:45 EDT 19 Oct 2018 | Nature Publishing

More From BioPortfolio on "YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect"